Alpha Tau Medical Ltd (DRTS)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Alpha Tau Medical Ltd (DRTS) is up 80.4% since the beginning of the year. At $9 per share, DRTS is trading 23.1% below its 52-week high of $12. Investors who bought $1,000 worth of DRTS shares 5 years ago would now be looking at an investment worth $926.

Alpha Tau Medical Ltd (DRTS) has returned 80.40% so far this year and 204.78% over the past 12 months.

Based on dividend-adjusted daily data since Mar 8, 2021, DRTS's average daily return is +0.10%, while the average monthly return is +0.99%. At this rate, an investment would double in approximately 5.9 years.

Historically, 52% of months were positive and 48% were negative. The best month was Jan 2026 with a return of +40.2%, while the worst month was Aug 2022 at -30.6%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 5 months.

On a daily basis, DRTS closed higher 45% of trading days. The best single day was Jun 10, 2022 with a return of +40.2%, while the worst single day was May 11, 2022 at -25.3%.

Alpha Tau Medical Ltd has an annualized alpha of 19.98%, beta of 0.54, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since March 09, 2021.

• This stock participated in 146.60% of S&P 500 Index downside but only 83.69% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.54 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

DRTS ranks 93 for risk / return — in the top 93% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Alpha Tau Medical Ltd (DRTS) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Alpha Tau Medical Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alpha Tau Medical Ltd was 86.86%, occurring on Aug 6, 2024. The portfolio has not yet recovered.

The current Alpha Tau Medical Ltd drawdown is 41.63%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Alpha Tau Medical Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Alpha Tau Medical Ltd is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.